#United States #New York #Class Action #Pomerantz Law Firm #Reckitt Benckiser

Pomerantz Law Firm Addresses Investors of Reckitt Benckiser Group Plc

On July 2, 2025, Pomerantz LLP made a significant announcement concerning a class action lawsuit filed against Reckitt Benckiser Group Plc. This important legal action could impact investors who have sustained losses on their investments in Reckitt. If you're one of these individuals, it is crucial that you are aware of your rights and the steps you can take moving forward.

A Call for Investors to Join the Class Action

The lawsuit targets Reckitt and various officers or directors of the company, questioning their involvement in securities fraud and other illegal business practices. If you purchased Reckitt securities during the Class Period, you may be eligible to participate in the class action. Investors have until August 4, 2025, to request the Court appoint them as the Lead Plaintiff. Interested parties can contact Pomerantz at Danielle Peyton via email at [email protected] or call 646-581-9980. For those inquiring via email, it’s advisable to include critical information such as your physical address, phone number, and the number of shares you acquired.

Recent Developments Leading to the Lawsuit

The backdrop of this lawsuit lies in a series of troubling verdicts against Reckitt's Mead Johnson subsidiary. On March 15, 2024, an Illinois jury awarded $60 million to plaintiffs who claimed that Mead Johnson was negligent for not warning consumers about the risks associated with its cow’s milk-based formula. This formula was linked to the development of necrotizing enterocolitis (NEC) in preterm infants.

Following this news, Reckitt's American Depositary Share (ADS) witnessed a significant decline, dropping $1.87 or nearly 14%, closing at $11.44. The situation further deteriorated for Reckitt on July 29, 2024, when another jury awarded $495 million to plaintiffs in a case against Abbott Laboratories, citing similar negligence regarding the risk associated with its specialized baby formula.

The impact of this verdict saw Reckitt's ADS price fall by $1.02, or almost 9%, concluding at $10.64. These losses exemplify the pressing issues that Reckitt investors face as concerns over accountability and corporate governance continue to mount.

Pomerantz LLP’s Legacy

With a history that spans over 85 years, Pomerantz LLP is distinguished for its role in class-action litigation related to corporate, securities, and antitrust matters. Founded by Abraham L. Pomerantz, known as the dean of the class action bar, the firm has a strong reputation for championing the rights of victims of securities fraud and corporate misconduct. With offices in major cities including New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, Pomerantz has successfully recovered substantial damage awards for class members impacted by corporate malfeasance.

In light of the current legal proceedings against Reckitt, affected investors are strongly encouraged to reach out to Pomerantz LLP. More information regarding the lawsuit is accessible through the firm’s website at www.pomerantzlaw.com.

Conclusion

As the situation unfolds, the class action lawsuit against Reckitt Benckiser presents a pivotal moment for investors impacted by recent business decisions. By engaging with this legal action, investors can not only seek potential compensation for their losses but also promote greater accountability within corporate structures. Be vigilant and proactive in protecting your investment rights in these challenging times.